Copyright 2009 Medical News Today Latest Parkinson's Disease News From Medical News Today. http://www.medicalnewstoday.com/sections/parkinsons_disease/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Thu, 09 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156796.php http://www.medicalnewstoday.com/articles/156796.php The latest work to 'turn off the taps' in the brain and stop a chemical being released in excess amounts which can lead to Parkinson's Disease - was presented at The British Pharmacological Society's Summer Meeting in Edinburgh. Parkinson's Disease Tue, 07 Jul 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/156586.php http://www.medicalnewstoday.com/articles/156586.php With neuroscience on the threshold of unprecedented advances in understanding and treating Alzheimer's disease, Parkinson's disease, autism, and a range of other disorders of the brain and nervous system, the American Chemical Society (ACS) has announced plans to launch a new journal devoted to the molecular basis of neurological disease. ACS Chemical Neuroscience will launch in January 2010 with Craig W. Lindsley, Ph.D. Neurology / Neuroscience Tue, 07 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156507.php http://www.medicalnewstoday.com/articles/156507.php A new study by researchers at Rhode Island Hospital have found a substantial link between increased levels of nitrates in our environment and food, with increased deaths from diseases, including Alzheimer's, diabetes mellitus and Parkinson's. The study was published in the Journal of Alzheimer's Disease (Volume 17:3 July 2009). Alzheimer's / Dementia Mon, 06 Jul 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/156394.php http://www.medicalnewstoday.com/articles/156394.php Existing drugs used in the treatment of Parkinson's disease could be repositioned for use in the treatment of extreme drug-resistant tuberculosis, which kills about 2 million people each year, according to a study led by researchers at the University of California, San Diego. The rise of these strains of TB throughout the world, including industrialized countries, poses a great threat to human health. Parkinson's Disease Thu, 02 Jul 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/156052.php http://www.medicalnewstoday.com/articles/156052.php A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make. The test was developed by Dr. Mark Gluck, professor of neuroscience at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark, working with co-researchers at Rutgers, New York University, and in Hungary. Parkinson's Disease Wed, 01 Jul 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/156014.php http://www.medicalnewstoday.com/articles/156014.php Neural stem cells represent the cellular backup of our brain. These cells are capable of self-renewal to form new stem cells or differentiate into neurons, astrocytes or oligodendrocytes. Astrocytes have supportive functions in the environment of neurons, while oligodendrocytes form the myelin layer around axons in order to accelerate neuronal signal transmission. Stem Cell Research Tue, 30 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155718.php http://www.medicalnewstoday.com/articles/155718.php UCB announced that Neupro(R) (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009. Parkinson's Disease Mon, 29 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/155690.php http://www.medicalnewstoday.com/articles/155690.php UCB announced that Neupro® (rotigotine transdermal patch) can now be prescribed to all patients with idiopathic Parkinson's disease in Europe and is newly available for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome (RLS) in adults. This follows the decision of the European Commission to lift treatment restrictions on Neupro® in line with the recommendation of the European Medicines Agency (EMEA), issued on 29 May 2009. Parkinson's Disease Sun, 28 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155570.php http://www.medicalnewstoday.com/articles/155570.php Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin®/ Sifrol® (pramipexole), in all countries of the European Union, Norway, Iceland and Liechtenstein. Parkinson's Disease Sun, 28 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155556.php http://www.medicalnewstoday.com/articles/155556.php The University of Texas Health Science Center at Houston has received a $412,500 federal stimulus grant for Parkinson's disease research, the university announced today. It is the university's first federal stimulus grant. Parkinson's disease is an incurable brain disorder. Its symptoms include trembling, stiffness and problems with balance. An estimated one million Americans are diagnosed with the neurological disorder. Parkinson's Disease Sat, 27 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155588.php http://www.medicalnewstoday.com/articles/155588.php An enzyme that naturally occurs in the brain helps destroy the mutated protein that is the most common cause of inherited Parkinson's disease, researchers at UT Southwestern Medical Center have found. Their study, using human cells, provides a focus for further research into halting the action of the mutated protein. One of the most famous carriers of the mutation is Google co-founder Sergey Brin, who wrote about it on his blog in 2008. Parkinson's Disease Fri, 26 Jun 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/155511.php http://www.medicalnewstoday.com/articles/155511.php An enzyme that naturally occurs in the brain helps destroy the mutated protein that is the most common cause of inherited Parkinson's disease, researchers at UT Southwestern Medical Center have found. Their study, using human cells, provides a focus for further research into halting the action of the mutated protein. One of the most famous carriers of the mutation is Google co-founder Sergey Brin, who wrote about it on his blog in 2008. Parkinson's Disease Thu, 25 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155216.php http://www.medicalnewstoday.com/articles/155216.php The classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements. Over the last decade, neurologists have been paying greater attention to non-motor symptoms, such as digestive and sleep problems, loss of sense of smell and depression. Parkinson's Disease Tue, 23 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/154919.php http://www.medicalnewstoday.com/articles/154919.php An important problem of patients with PD is not related to dopamine deficit. "PD patients suffer not only of motor but also of such non-motor disturbances as sleep disturbances, depression, psychosis, hallucinations or dementia. These disturbances require a precise diagnostic work up and specific, usually non dopaminergic medications." A whole series of studies being presented at the ENS meeting are devoted to this problem area. Parkinson's Disease Tue, 23 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/154920.php http://www.medicalnewstoday.com/articles/154920.php There is also increasing knowledge about higher frequency of compulsive behavior in patients with PD compared to the general population. "These impulse control disorders such as pathological gambling, hyper-sexuality, compulsive shopping, compulsive eating or compulsive overuse of dopaminergic drugs can lead to monetary losses or worsen social handicap of PD patients," Professor Bassetti explains. Parkinson's Disease Fri, 19 Jun 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/154602.php http://www.medicalnewstoday.com/articles/154602.php Senator Byron Dorgan (ND) on Tuesday introduced legislation that would for the first time establish a national coordinated system to collect and analyze data on multiple sclerosis and Parkinson's disease. Accurate incidence and prevalence information on these two diseases currently does not exist. Click here to ask your Senator to support this legislation. Parkinson's Disease Fri, 19 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/154539.php http://www.medicalnewstoday.com/articles/154539.php The National Resource for Aplysia at the University of Miami's Rosenstiel School of Marine & Atmospheric Science has had its resources grant with the National Institute for Health (NIH) extended for an additional five years. The National Resource for Aplysia is the only facility in the world that cultures and raises Aplysia californica, commonly known as sea hares or sea slugs. Over the course of the next five years, the facility will receive $2. Neurology / Neuroscience Thu, 18 Jun 2009 08:00:00 PDT http://www.medicalnewstoday.com/articles/154489.php http://www.medicalnewstoday.com/articles/154489.php As part of a Europe-wide drive to improve access to information and education for people with Parkinson's Disease, the Parkinson's Disease Society (PDS) is launching a new education initiative with American company, Healthy Interactions. The Conversation Map™ tools will address the needs of people at all stages of Parkinson's and those of their families and carers. Parkinson's Disease Wed, 17 Jun 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/154226.php http://www.medicalnewstoday.com/articles/154226.php When: 8 July 2009 6:00pm - 8:00pm What: Launch of the APPG's report into inequalities of access to services for people with Parkinson's and their carers. In response to the report, the Parkinson's Disease Society will also launch Fair Care for Parkinson's, calling for the Government to ensure the APPG report recommendations are carried out. Parkinson's Disease Sat, 13 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/153824.php http://www.medicalnewstoday.com/articles/153824.php A research group based at the University of Granada, in cooperation with the Neurology Unit of the San Cecilio Hospital of Granada and the Department of Experimental Sciences of the University of Jaen, is studying the Neurobiology of Parkinson's disease (PD). They have developed a non-invasive method for serological diagnosis of Parkinson's disease, which is being patented by the University of Granada. Parkinson's Disease Sat, 13 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/153657.php http://www.medicalnewstoday.com/articles/153657.php The Nintendo Wii may help treat symptoms of Parkinson's disease, including depression, a Medical College of Georgia researcher says. Parkinson's disease is a degenerative disease that impairs motor skills. Dr. Herz theorized that the popular computer game console, which simulates various sports and activities, could improve coordination, reflexes and other movement-related skills, but he found additional benefits as well. Parkinson's Disease Fri, 12 Jun 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/153549.php http://www.medicalnewstoday.com/articles/153549.php New data presented at the 13th International Congress of Parkinson's Disease and Movement Disorders show that Requip-Modutab* (ropinirole prolonged release tablets) improves nocturnal symptoms experienced by patients with advanced Parkinson's disease (PD).[i] The data showed that patients with more significant nocturnal symptoms had a greater improvement with Requip-Modutab, when used as an adjunct to levodopa (L-dopa), versus placebo. Parkinson's Disease Thu, 11 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/153404.php http://www.medicalnewstoday.com/articles/153404.php Scientists at Weill Cornell Medical College have developed a new mouse model of Parkinson's disease (PD) that successfully reproduces the impairments of movement and the degenerative brain changes that occur in the human disease. Their research, performed in collaboration with investigators at Columbia University Medical Center, appears in the June 7 issue of the journal Nature Neuroscience. Parkinson's Disease Thu, 11 Jun 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/153407.php http://www.medicalnewstoday.com/articles/153407.php The European Parkinson's Disease Association (EPDA) announces the launch today of multiple language versions of its pan-European awareness campaign, Life with Parkinson's at the International Congress of Parkinson's Disease and Movement Disorders. Parkinson's Disease Wed, 10 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/153207.php http://www.medicalnewstoday.com/articles/153207.php Teva Neuroscience, Inc. presented results from a clinical pharmacology study in which AZILECT(R) (rasagiline tablets) did not increase the risk of tyramine sensitivity at the maximum approved dose of 1 mg. The presentation was made during the 13th International Congress of Parkinson's Disease and Movement Disorders in Paris, France. Parkinson's Disease